Particle.news
Download on the App Store
16 ARTICLES
·
5d ago

Risk Assessment Spurs Early HER2-Positive Diagnosis for Olivia Munn’s Mother

Prompted by a 26.2 percent Tyrer-Cuzick lifetime risk score, Kim Munn underwent MRI screening that revealed Stage 1 HER2-positive breast cancer, leading to a double mastectomy, chemotherapy, Herceptin infusions through fall.

Olivia Munn with her mother Kim during chemotherapy.
Image

Overview

  • The online Tyrer-Cuzick Breast Cancer Lifetime Risk Assessment highlighted a high lifetime risk despite a clear mammogram and led to follow-up MRI imaging.
  • Medical imaging confirmed Stage 1 HER2-positive breast cancer, and Kim Munn underwent a double mastectomy.
  • She has completed 12 rounds of chemotherapy and will continue monthly Herceptin treatments until this fall.
  • Olivia Munn and her mother now share an oncologist, and Olivia has spent nights at her bedside during taxing chemotherapy sessions.
  • Physicians now advise integrating routine lifetime risk assessments into women’s health protocols starting at age 30 or after significant hormonal or family history changes.